Phase 1 Papulopustular Rosacea Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Completed
Phase 1
A Randomised, Double-Blind, Vehicle-Controlled Study of the Safety and Tolerability of BTX 1702 in Patients with Papulopustular Rosacea
Papulopustular Rosacea
Botanix Pharmaceuticals Ltd120 enrolled1 locationACTRN12621000689875
Withdrawn
Phase 1
A Randomised, Double-Blind, Vehicle-Controlled Study of the Safety and Tolerability of Two Dosage Forms of BTX 1702 in Patients with Papulopustular Rosacea
Papulopustular Rosacea
Botanix Pharmaceuticals Ltd120 enrolled1 locationACTRN12620000184976